Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Folia Health | 2025 | Series A | $10.5M | Cambridge |
| Sunwealth Power | 2025 | Debt Financing | $20.0M | Somerville |
| Scout Space | 2025 | Grant | $1.3M | Reston |
| Hubble Network | 2025 | Series B | $70.0M | Las Vegas |
| Neurosoft Bioelectronics | 2025 | Seed | Undisclosed | Geneva |
| Yeastime | 2025 | Series Unknown | $995K | Rome |
| Cariina | 2025 | Seed | $3.0M | Boston |
| HeroSupport | 2025 | Grant | Undisclosed | Veyrier |
| Resistell AG | 2025 | Grant | Undisclosed | Basel |
| EarlySight | 2025 | Seed | $3.9M | Lausanne |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 201 | Folia Health | Series A | $10.5M | Cambridge, United States |
| 202 | Sunwealth Power | Debt Financing | $20.0M | Somerville, United States |
| 203 | Scout Space | Grant | $1.3M | Reston, United States |
| 204 | Hubble Network | Series B | $70.0M | Las Vegas, United States |
| 205 | Neurosoft Bioelectronics | Seed | Undisclosed | Geneva, Switzerland |
| 206 | Yeastime | Series Unknown | $995K | Rome, Italy |
| 207 | Cariina | Seed | $3.0M | Boston, United States |
| 208 | HeroSupport | Grant | Undisclosed | Veyrier, Switzerland |
| 209 | Resistell AG | Grant | Undisclosed | Basel, Switzerland |
| 210 | EarlySight | Seed | $3.9M | Lausanne, Switzerland |
Folia Health is a platform that captures and shares secure health and symptom data for users.
Sunwealth Power is a operator of a tech-driven clean energy investment firm created to invest in clean and solar energy projects
Scout is developing orbital products and services to enable a new era of space safety, transparency, and improved Space Domain Awareness.
Hubble Network is a developer of a satellite-powered Bluetooth network that enables devices to connect regardless of cellular reception.
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system.
Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.
Organizational Management Platform for K-12 Schools.
HeroSupport transforms imaging and/or treatment tables into personalized solutions.
Resistell is a antibiotic resistance test.
EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
Nagi Bioscience aims to revolutionize the way toxic and beneficial effects of substances are tested.
IMMA is reinventing the fertility journey by offering women a self-operated remote device.
Phytolon offers natural food colors in high quality at low costs.
Verqor is a platform that gives cashless credits to farmers for productive purchases.
Alkymi is the first end-to-end solution for turning your private markets data into actionable insights.
Autonomous Healthcare is a medical technology company pioneering the use of automation in clinical care workflows
Encapsulate is a biotechnology company that offers precision diagnostics for cancer therapy.
RenewCO2 is a research company that develops processes for converting CO2 into chemicals and fuels.
LIfT Biosciences is a biotech company that develops allogeneic cell therapies using induced pluripotent stem cells.
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
Candam specializes in developing technology for the waste management solutions sector.
Automating Engineering Workflows with AI
Retirable is a financial services technology company specializing in retirement planning, advising, and income generation.
CREAL develops near-eye light-field display bringing true optical depth and better immersion into virtual and mixed reality.
Advanced tech-enabled devices providing complete rehabilitation solutions for mobility challenges.
MassChallenge has invested in 807 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
MassChallenge's top investment sectors include Health Care, Software, Medical Device, Biotechnology, Life Science. The firm invests across 52 different industry categories.
Among tracked funding rounds, Hubble Network received $70.0M in a Series B round. MassChallenge's total known invested capital is $3.4B.
MassChallenge's average investment size is $6.6M across its portfolio of 807 companies.
Recent MassChallenge portfolio additions include Folia Health, Sunwealth Power, Scout Space, Hubble Network, Neurosoft Bioelectronics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors